收藏本站
我的資料
我的訂單
  購(gòu)物車 (0)  
親,您的購(gòu)物車空空的喲~
去購(gòu)物車結(jié)算
   
查看手機(jī)網(wǎng)站
其他賬號(hào)登錄: 注冊(cè) 登錄
150-21460884
產(chǎn)品分類
Ursodeoxycholic Acid-d4 
Ursodeoxycholic Acid-d4
收藏
|
|
英文名稱 : Ursodeoxycholic Acid-d4
貨號(hào) : EY-01Y17493
CAS : 347841-46-7
含量 : >99.00%
規(guī)格 : 500 μg、1 mg、5 mg
品牌 : 上海一研
價(jià)格 :
0.00
購(gòu)買數(shù)量:
加入購(gòu)物車  立即購(gòu)買
產(chǎn)品保證
正品保證
快速發(fā)貨
產(chǎn)品詳情
產(chǎn)品評(píng)論(0)
銷售記錄(0)

產(chǎn)品屬性:


產(chǎn)品名稱

Ursodeoxycholic Acid-d4

規(guī)格

500 μg、1 mg、5 mg

貨號(hào)

EY-01Y17493

Cas No.: 347841-46-7

別名: N/A

化學(xué)名: N/A

分子式: C24H36D4O4
GC48230.png
分子量: 396.6

溶解度: DMF: 10 mg/ml,DMSO: 10 mg/ml,DMSO:PBS(pH 7.2) (1:4): 0.2 mg/ml,Ethanol: 1 mg/ml

儲(chǔ)存條件: Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

Shipping ConditionEvaluation sample solution : ship with blue ice

All other available size: ship with RT , or blue ice upon request

產(chǎn)品描述:


Ursodeoxycholic acid-d4 (UDCA-d4) is intended for use as an internal standard for the quantification of UDCA by GC- or LC-MS. UDCA is a secondary bile acid formed via epimerization of chenodeoxycholic acid .1,2 UDCA is also a metabolite of lithocholic acid in human liver microsomes.3 It inhibits taurocholic acid uptake in HeLa cells expressing recombinant sodium/taurocholate cotransporting polypeptide (NTCP) with an IC50 value of 3.6 μM.4 UDCA (50 μM) inhibits apoptosis induced by deoxycholic acid or ethanol in primary rat hepatocytes.5 Dietary administration of UDCA blocks DCA-induced increases in the number of TUNEL-positive hepatocytes in rats. Formulations containing UDCA have been used in the treatment of primary biliary cirrhosis.1.Dawson, P.A., and Karpen, S.J.Intestinal transport and metabolism of bile acidsJ. Lipid Res.56(6)1085-1099(2015)

2.Chiang, J.Y.L.Bile acid metabolism and signaling in liver disease and therapyLiver Res.1(1)3-9(2017)

3.Deo, A.K., and Bandiera, S.M.3-Ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acidDrug Metab. Dispos.37(9)1938-1947(2009)

4.Kim, R.B., Leake, B., Cvetkovic, M., et al.Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activityJ. Pharmacol. Exp. Ther.291(3)1204-1209(1999)

5.Rodrigues, C.M.P., Fan, G., Ma, X., et al.A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbationJ. Clin. Invest.101(12)2790-2799(1998)
特別提醒公司產(chǎn)品僅供科研使用


買家數(shù)量成交時(shí)間
正品保障

確保所有產(chǎn)品都是原裝正品

優(yōu)質(zhì)服務(wù)

優(yōu)質(zhì)服務(wù),售后無憂

安全包裝

統(tǒng)一包裝,保障產(chǎn)品安全運(yùn)輸

正規(guī)發(fā)票

機(jī)打發(fā)票,附箱送達(dá)

    配送方式            新手入門           售后服務(wù)           幫助中心           支付方式           關(guān)于我們
      包裝說明                會(huì)員服務(wù)                退款說明                服務(wù)協(xié)議               預(yù)付賬戶               聯(lián)系一研
      商品驗(yàn)收                積分規(guī)則               退換款地址            投訴建議                發(fā)票制度
      配送查詢                購(gòu)物流程                退換款流程            聯(lián)系客服               付款周期
      配送說明                會(huì)員體系                退換款原則            找回密碼               付款方式
手機(jī)掃一掃
訪問手機(jī)網(wǎng)站